UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000043026
Receipt number R000049118
Scientific Title Open study on safety and efficacy of "mulberry leaf green juice" or "baby oligo (kestose)" in pregnant females
Date of disclosure of the study information 2021/01/16
Last modified on 2021/07/31 16:07:30

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study to test the efficacy of "mulberry leaf green juice" or "baby oligo (kestose)" in improving intestinal environment in pregnant females

Acronym

A study to test the efficacy of prebiotics in improving intestinal environment

Scientific Title

Open study on safety and efficacy of "mulberry leaf green juice" or "baby oligo (kestose)" in pregnant females

Scientific Title:Acronym

Open study on safety and efficacy of prebiotics in pregnant females

Region

Japan


Condition

Condition

Pregnant females

Classification by specialty

Gastroenterology Obstetrics and Gynecology Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to examine the safety and efficacy in ameliorating intestinal environment of green mulberry leaf juice and kestose administered for 12 weeks in pregnant women 20 to 45 years of age

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Enteric environment (bifidobacterium, Bacteroides, Prevotella, Clostridium, total bacterial count et al.)

Key secondary outcomes

Urinary indoxyl sulfate
Urinary creatinine
Urinary 8-OHdG
Salivary IgA
Questionnaire survey
Safety assessment


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Dose comparison

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Ingested food : "mulberry leaf green juice"
Dose : Two packets per day Drink
Period : 12 weeks

Interventions/Control_2

Ingested food : "baby oligo (kestose)"
Dose : Two packets per day Drink
Period : 12 weeks

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

45 years-old >

Gender

Female

Key inclusion criteria

1)Patients who have received adequate explanation of the purpose and content of this study, are able to give informed consent, voluntarily volunteer after fully understood, and agree to participate in writing.
2)Japanese people aged 20 to <45 years at the time of informed consent
3)Those who between 12 and 25 weeks' gestation at baseline

Key exclusion criteria

1)Patients with chronic disease who are receiving drug treatment or who have a history of disease
2)Individuals with allergies, etc. to the test article
3)Those currently taking foods or green juice containing mulberry leaf regularly
4)Those currently taking prebiotic or probiotic formulation or foods regularly
5)Those currently taking drugs, specified insurance foods, or health foods that may affect bowel movements
6)Those currently participating in another clinical trial or have participated in another clinical trial within 3 months prior to the start of the present study.
7)Women judged by the attending physicians and principal investigator as being inappropriate candidates for inclusion in the study.

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Yoshizumi
Middle name
Last name Sato

Organization

Natural Science Co.,Ltd.

Division name

Research and Development Department

Zip code

136-0073

Address

3-4-27 Kitasuna, Koto-ku, Tokyo 136-0073, JAPAN

TEL

0356652311

Email

y.sato@natural-s.jp


Public contact

Name of contact person

1st name Nozomi
Middle name
Last name Ando

Organization

Natural Science Co.,Ltd.

Division name

Research and Development Department

Zip code

136-0073

Address

3-4-27 Kitasuna, Koto-ku, Tokyo 136-0073, JAPAN

TEL

0356652311

Homepage URL


Email

ando@natural-s.jp


Sponsor or person

Institute

Natural Science Co.,Ltd.
Research and Development Department

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

Kanagawa Midwives Association
B Food Science Co., Ltd.
Healthcare Systems Co., Ltd.

Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Ethics Committee of Healthcare Systems Co., Ltd.

Address

Nisshin Tatemono Shinbashi Bld. 7F, 4-6-15 Shinbashi, Minato-ku, Tokyo, JAPAN

Tel

0368092722

Email

soumu@hc-sys.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

ウパウパハウス 岡本助産院、かもめ助産院、とわ助産院、みどり助産院、横須賀マタニティクリニック、めぐみ助産院、森重助産院 (いずれも神奈川県)
UPAUPAHOUSE okamotojosanin、Kamome Maternity Clinic、Towa jyosanin、Midori jyosanin、Yokosuka Maternity Clinic、Megumi jyosanin、Morishige jyosanin (All Kanagawa)


Other administrative information

Date of disclosure of the study information

2021 Year 01 Month 16 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 08 Month 26 Day

Date of IRB

2020 Year 09 Month 10 Day

Anticipated trial start date

2020 Year 09 Month 23 Day

Last follow-up date

2021 Year 07 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 01 Month 16 Day

Last modified on

2021 Year 07 Month 31 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049118


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name